EMA Authorised: Omvoh (mirikizumab) — Eli Lilly Nederland B.V.

View source ↗

Summary

EU authorised Omvoh (mirikizumab) for ulcerative colitis; Eli Lilly Nederland B.V. is the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• OMVOH (MIRIKIZUMAB-MRKZ)

Snippet

Status: Authorised. Therapeutic area: Colitis, Ulcerative. MAH: Eli Lilly Nederland B.V.. Decision date: 27/01/2026